Synthesis, Antibacterial Evaluation, and Computational Studies of a Diverse Set of Linezolid Conjugates

The development of new antibiotics to treat multidrug-resistant (MDR) bacteria or possess broad-spectrum activity is one of the challenging tasks. Unfortunately, there are not many new antibiotics in clinical trials. So, the molecular hybridization approach could be an effective strategy to develop potential drug candidates using the known scaffolds. We synthesized a total of 31 diverse linezolid conjugates 3, 5, 7, 9, 11, 13, and 15 using our established benzotriazole chemistry with good yield and purity. Some of the synthesized conjugates exhibited promising antibacterial properties against different strains of bacteria. Among all the synthesized compounds, 5d is the most promising antibacterial agent with MIC 4.5 mu M against S. aureus and 2.25 mu M against B. subtilis. Using our experimental data pool, we developed a robust QSAR (R-2 = 0.926, 0.935; R(2)cvOO = 0.898, 0.915; R(2)cvMO = 0.903, 0.916 for the S. aureus and B. subtilis models, respectively) and 3D-pharmacophore models. We have also determined the drug-like properties of the synthesized conjugates using computational tools. Our findings provide valuable insight into the possible linezolid-based antibiotic drug candidates.

Automated summary

The development of new antibiotics using known scaffolds through molecular hybridization is an effective strategy. In this study, researchers synthesized diverse linezolid conjugates and identified one with promising antibacterial activity. They also developed QSAR and 3D-pharmacophore models to evaluate the drug-like properties of the synthesized compounds.